[1]
“Comparative Cardioprotective Effects of SGLT2 Inhibitors in Preclinical Models of Diabetic Cardiomyopathy”, VER, vol. 8, no. 20s, pp. 1–9, Dec. 2025, doi: 10.64149/J.Ver.8.20s.1-9.